# Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region

> **NCT02119780** · NA · UNKNOWN · sponsor: **LG Life Sciences** · enrollment: 83 (estimated)

## Conditions studied

- Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region

## Interventions

- **DEVICE:** YVOIRE® contour
- **DEVICE:** Restylane SubQ™

## Key facts

- **NCT ID:** NCT02119780
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 83 (ESTIMATED)
- **Last updated:** 2015-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02119780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02119780, "Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02119780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*